Birdwatch Note
2023-03-14 16:11:20 UTC - NOT_MISLEADING
Per article, which is not behind a paywall, Lemoi was recommending dosages shown to be toxic in humans and telling his followers that the negative side effects were ok. Article makes clear this is about veterinary grade ivermectin. Tweet isn’t misleading. Notes not needed.
Written by 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1635623681522114564
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1635674983891636224
- noteId - 1635674983891636224
- participantId -
- noteAuthorParticipantId - 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C Participant Details
- createdAtMillis - 1678810280189
- tweetId - 1635623681522114564
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 1
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 1
- trustworthySources - 1
- summary
- Per article, which is not behind a paywall, Lemoi was recommending dosages shown to be toxic in humans and telling his followers that the negative side effects were ok. Article makes clear this is about veterinary grade ivermectin. Tweet isn’t misleading. Notes not needed.
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-03-14 16:11:20 UTC (1678810280189) |
1969-12-31 23:59:59 UTC (-1) |
2023-03-15 05:09:59 UTC (1678856999448) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-03-14 20:58:39 -0500 | Rating Details | |
| 2023-03-14 20:05:32 -0500 | Rating Details | |
| 2023-03-14 19:27:49 -0500 | Rating Details | |
| 2023-03-14 17:40:50 -0500 | Rating Details | |
| 2023-03-14 17:40:41 -0500 | Rating Details | |
| 2023-03-14 17:06:08 -0500 | Rating Details | |
| 2023-03-14 16:42:40 -0500 | Rating Details | |
| 2023-03-14 16:28:44 -0500 | Rating Details | |
| 2023-03-14 16:20:04 -0500 | Rating Details | |
| 2023-03-14 15:36:38 -0500 | Rating Details | |
| 2023-03-14 14:09:47 -0500 | Rating Details | |
| 2023-03-14 13:26:42 -0500 | Rating Details | |
| 2023-03-14 13:25:16 -0500 | Rating Details | |
| 2023-03-14 13:08:34 -0500 | Rating Details | |
| 2023-03-14 12:56:27 -0500 | Rating Details | |
| 2023-03-14 12:37:06 -0500 | Rating Details | |
| 2023-03-14 12:20:34 -0500 | Rating Details | |
| 2023-03-14 11:55:17 -0500 | Rating Details | |
| 2023-03-14 11:54:45 -0500 | Rating Details | |
| 2023-03-14 11:45:16 -0500 | Rating Details | |
| 2023-03-14 11:40:56 -0500 | Rating Details | |
| 2023-03-14 11:28:26 -0500 | Rating Details | |
| 2023-03-14 11:18:25 -0500 | Rating Details | |
| 2023-03-15 13:35:21 -0500 | Rating Details | |
| 2023-03-15 10:31:56 -0500 | Rating Details | |
| 2023-03-15 05:53:55 -0500 | Rating Details | |
| 2023-03-15 01:48:23 -0500 | Rating Details | |
| 2023-03-15 00:21:32 -0500 | Rating Details | |
| 2023-03-15 00:21:20 -0500 | Rating Details | |
| 2023-03-14 22:45:46 -0500 | Rating Details | |
| 2023-03-15 23:04:55 -0500 | Rating Details | |
| 2023-03-14 17:40:50 -0500 | Rating Details | |
| 2023-03-15 01:48:23 -0500 | Rating Details | |
| 2023-03-14 16:42:40 -0500 | Rating Details | |
| 2023-03-15 23:04:55 -0500 | Rating Details | |
| 2023-03-14 12:37:06 -0500 | Rating Details | |
| 2023-03-14 20:05:32 -0500 | Rating Details | |
| 2023-03-14 13:26:42 -0500 | Rating Details | |
| 2023-03-15 00:21:20 -0500 | Rating Details | |
| 2023-03-14 13:25:16 -0500 | Rating Details | |
| 2023-03-14 11:18:25 -0500 | Rating Details | |
| 2023-03-15 10:31:56 -0500 | Rating Details | |
| 2023-03-14 13:08:34 -0500 | Rating Details | |
| 2023-03-15 00:21:32 -0500 | Rating Details | |
| 2023-03-14 14:09:47 -0500 | Rating Details | |
| 2023-03-14 16:28:44 -0500 | Rating Details | |
| 2023-03-15 13:35:21 -0500 | Rating Details | |
| 2023-03-14 19:27:49 -0500 | Rating Details | |
| 2023-03-14 17:40:41 -0500 | Rating Details | |
| 2023-03-14 11:40:56 -0500 | Rating Details | |
| 2023-03-14 12:56:27 -0500 | Rating Details | |
| 2023-03-14 20:58:39 -0500 | Rating Details | |
| 2023-03-15 05:53:55 -0500 | Rating Details | |
| 2023-03-14 11:45:16 -0500 | Rating Details | |
| 2023-03-14 22:45:46 -0500 | Rating Details | |
| 2023-03-14 12:20:34 -0500 | Rating Details | |
| 2023-03-14 15:36:38 -0500 | Rating Details | |
| 2023-03-14 17:06:08 -0500 | Rating Details | |
| 2023-03-14 16:20:04 -0500 | Rating Details | |
| 2023-03-14 11:55:17 -0500 | Rating Details | |
| 2023-03-14 11:28:26 -0500 | Rating Details | |
| 2023-03-14 11:54:45 -0500 | Rating Details |